Niacinamide

DRUG12 trials

Conditions

Acute Kidney InjuryAcute SchizophreniaBladder CancerHodgkin's DiseaseHyperphosphatemiaHyperpigmentationIschemia Reperfusion InjuryMelasma

Early Phase 1

DNA Methylation in Malar Melasma and Its Change by Sunscreen, Retinoic Acid and Niacinamide.

CompletedNCT03392623

Universidad Autonoma de San Luis PotosíMelasma

Start: 2015-01-01End: 2016-12-01Updated: 2018-01-09

Phase 1

The Effect of Oral Niacinamide on Serum Phosphorus Levels in Hemodialysis Patients

CompletedNCT00316472

Washington University School of MedicineHyperphosphatemia

Start: 2006-04-30End: 2007-12-31Target: 40Updated: 2009-01-16

The Effect of Oral Niacinamide on Plasma Phosphorus Levels in Peritoneal Dialysis Patients

CompletedNCT00508885

Washington University School of MedicineHyperphosphatemia

Start: 2006-10-31End: 2007-07-31Updated: 2007-07-30

Phase I Vorinostat in Combination With Niacinamide and Etoposide for Lymphoid Malignancies

CompletedNCT00691210

Columbia UniversityHodgkin's Disease, Non-Hodgkin's Lymphoma

Start: 2008-06-30End: 2015-03-31Updated: 2020-11-20

Nutrition, Neuromuscular Electrical Stimulation (NMES) and Secondary Progressive Multiple Sclerosis (SPMS)

CompletedNCT01381354

University of IowaMultiple Sclerosis

Start: 2010-10-31End: 2016-05-31Updated: 2018-06-26

Phase 2

Uncontrolled, Open Label, Pilot and Feasibility Study of Niacinamide in Polycystic Kidney Disease

CompletedNCT02140814

Alan Yu, MB, BChirPolycystic Kidney Disease

Start: 2014-05-31Updated: 2016-12-01

Pilot Study of Niacinamide in Polycystic Kidney Disease (NIAC-PKD2)

CompletedNCT02558595

University of Kansas Medical CenterPolycystic Kidney Disease

Start: 2015-09-22End: 2017-12-18Updated: 2019-02-11

NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury Trial

RecruitingNCT04750616

Kaiser PermanenteAcute Kidney Injury, Ischemia Reperfusion Injury, Myocardial Injury

Start: 2021-09-13End: 2025-06-30Target: 304Updated: 2025-03-12

Phase 3

Radiation Therapy With or Without Carbogen and Niacinamide in Treating Patients With Bladder Cancer

CompletedNCT00033436

Mount Vernon Cancer Centre at Mount Vernon HospitalBladder Cancer

Start: 2000-10-31End: 2008-11-30Target: 330Updated: 2013-09-20

Phase 4

Treatment of Acute Schizophrenia With Vitamin Therapy

CompletedNCT00140166

Beersheva Mental Health CenterAcute Schizophrenia

Start: 2005-07-31End: 2008-05-31Target: 55Updated: 2009-11-25

Clinical Trial of 4% Niacinamide Versus 0.05% Desonide for the Treatment of Axillar Hyperpigmentation

CompletedNCT01542138

Universidad Autonoma de San Luis PotosíHyperpigmentation

Start: 2011-07-31End: 2012-11-30Updated: 2012-11-29

Unknown Phase

Low Dose Niacin (Vitamin B3) for Parkinson's Disease

TerminatedNCT03808961

VA Office of Research and DevelopmentParkinson's Disease

Start: 2020-01-01End: 2023-11-01Updated: 2025-03-04

Related Papers

Hypofractionated radiotherapy in locally advanced bladder cancer: an individual patient data meta-analysis of the BC2001 and BCON trials.

2021-02-01106 citations

Long-term outcomes of hypoxia modification in bladder preservation: Update from BCON trial.

Journal of Clinical Oncology2019-03-0114 citations

Sirtuin and pan-class I/II deacetylase (DAC) inhibition is synergistic in preclinical models and clinical studies of lymphoma

Blood2013-08-0360 citations

The effect of oral niacinamide on plasma phosphorus levels in peritoneal dialysis patients.

2009-09-0136 citations